AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
155.75
+1.45 (0.94%)
Aug 14, 2025, 3:48 PM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $240.81 billion as of August 14, 2025. Its market cap has decreased by -2.32% in one year.
Market Cap
240.81B
Enterprise Value
266.48B
Revenue
56.50B
Ranking
n/a
PE Ratio
29.03
Stock Price
$155.75
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 240.81B, an increase of 3,291.21%. That is a compound annual growth rate of 11.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 243.29B | 19.75% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | 131.26B | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 597.56M |
| Elite Pharmaceuticals | 567.50M |
| Nika Pharmaceuticals | 360.27M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 325.38M |